Cover Image
市場調查報告書

Axxam SpA:產品平台分析

Axxam SpA - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251647
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
Axxam SpA:產品平台分析 Axxam SpA - Product Pipeline Review - 2015
出版日期: 2015年03月26日 內容資訊: 英文 20 Pages
簡介

Axxam SpA 是提供委託調查及藥物研發服務的供應商。服務的內容,是分子生物學、化驗開發、試劑的提供、化合物的管理、熱門商品的特徵和剖析、電生理學等的領域。還有疼痛、代謝障礙、老年癡呆症、發炎、自體免疫疾病治療等領域中也提供新藥開發計劃。

本報告提供Axxam SpA 的治療藥開發平台的現狀及各開發階段比較分析、各藥物標的、作用機制、給藥途徑、各分子類型的治療藥的評估、最新的企業新聞和發表、後期階段及中止的計劃相關資訊等。

Axxam SpA的基本資料

  • Axxam SpA概要
  • 主要資訊
  • 企業資料

Axxam SpA :R&D概要

  • 主要的治療範圍

Axxam SpA :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Axxam SpA :開發中產品概況

  • 初期階段的開發中產品
    • 藥物研發中的產品/聯合治療模式

Axxam SpA :藥物簡介

  • Small Molecules to Agonize CN2 Receptor for Pain
  • Small Molecules to Antagonize BDKRB1 for Pain and Ophthalmic Disorders
  • Small Molecules to Block Kv1.3 for CNS, Immunology, Gastrointestinal and Metabolic Disorders
  • Small Molecules to Block P2RX7 for CNS and Autoimmune Disorders

Axxam SpA :開發平台分析

  • 各標靶
  • 各分子類型
  • 各作用機制

Axxam SpA :暫停中的計劃

Axxam SpA :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06852CDB

Summary

Global Markets Direct's, 'Axxam SpA - Product Pipeline Review - 2015', provides an overview of the Axxam SpA's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Axxam SpA's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Axxam SpA including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Axxam SpA's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Axxam SpA's pipeline products

Reasons to buy

  • Evaluate Axxam SpA's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Axxam SpA in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Axxam SpA's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Axxam SpA and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Axxam SpA
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Axxam SpA and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Axxam SpA Snapshot
    • Axxam SpA Overview
    • Key Information
    • Key Facts
  • Axxam SpA - Research and Development Overview
    • Key Therapeutic Areas
  • Axxam SpA - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Axxam SpA - Pipeline Products Glance
    • Axxam SpA - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Axxam SpA - Drug Profiles
    • Small Molecules to Agonize CN2 Receptor for Pain
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Antagonize BDKRB1 for Pain and Ophthalmic Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Block Kv1.3 for CNS, Immunology, Gastrointestinal and Metabolic Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecules to Block P2RX7 for CNS and Autoimmune Disorders
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Axxam SpA - Pipeline Analysis
    • Axxam SpA - Pipeline Products by Target
    • Axxam SpA - Pipeline Products by Molecule Type
    • Axxam SpA - Pipeline Products by Mechanism of Action
  • Axxam SpA - Dormant Projects
  • Axxam SpA - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Axxam SpA, Key Information
  • Axxam SpA, Key Facts
  • Axxam SpA - Pipeline by Indication, 2015
  • Axxam SpA - Pipeline by Stage of Development, 2015
  • Axxam SpA - Monotherapy Products in Pipeline, 2015
  • Axxam SpA - Discovery, 2015
  • Axxam SpA - Pipeline by Target, 2015
  • Axxam SpA - Pipeline by Molecule Type, 2015
  • Axxam SpA - Pipeline Products by Mechanism of Action, 2015
  • Axxam SpA - Dormant Developmental Projects,2015
  • Axxam SpA, Other Locations

List of Figures

  • Axxam SpA - Pipeline by Top 10 Indication, 2015
  • Axxam SpA - Pipeline by Top 10 Target, 2015
  • Axxam SpA - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top